Event Details
Event Organiser: Oligonucleotide Therapeutics Society
Event Start Date: 25/11/2026
Event Start Time: 9am
Event End Time: 5pm
Event Address: The Ritz-Carlton, 1 Barrack St, Perth WA, Australia, 6000
Event Focus: Pharmaceutical
Event Type: Conference
Event Format: In-Person
Event Location: WA
Event Hosted By: Others
Inaugural Oligonucleotide Therapeutics Regional Meeting 2026 – Australia & New Zealand
The OTS Regional Meeting Australia – 2026 stands as a pivotal gathering for the global scientific community.
This conference serves as a dedicated platform for researchers, clinicians, and industry leaders to converge on the latest breakthroughs in oligonucleotide therapeutics. This inaugural meeting, supported through the OTS Regional Delivery Grant Scheme, will bring together 250–300 attendees from academia, biotechnology, and the pharmaceutical industry. The program will feature a strong international speaker lineup with a clear focus on advancing the field of oligonucleotide therapeutics.
By fostering deep collaboration and sharing visionary insights, we aim to accelerate the development of precision medicine solutions that redefine clinical outcomes and scientific innovation.
Why Attend OTS Australia 2026?
Join leading researchers, clinicians, biotechnology professionals and industry experts working across oligonucleotide and RNA therapeutics. OTS Australia 2026 will provide an opportunity to discover emerging research, exchange scientific insights, build collaborations and explore the future of RNA-based medicines.
- Hear from leading Australian and international experts.
- Discover advances in oligonucleotide and RNA therapeutics.
- Participate in scientific sessions and panel discussions.
- Connect with researchers, clinicians and industry leaders.
- Explore collaboration, research and commercialisation opportunities.
- Present your research through oral or poster presentations.
Find out more by visiting the website.
